- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 159-173 of
1,650 results
No. 71
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 71 (N.D.W.Va. Jan. 22, 2024)
|
|
Cite Document
No. 67
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 67 (N.D.W.Va. Jan. 11, 2024)
|
|
Cite Document
No. 52
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 52 (N.D.W.Va. Jan. 4, 2024)
|
|
Cite Document
No. 576
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 576 (N.D.W.Va. Jul. 7, 2023)
|
|
Cite Document
No. 552
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 552 (N.D.W.Va. Jun. 22, 2023)
|
|
Cite Document
8 Final Written Decision original: Final Written Decision original
Document
IPR2022-00298, No. 8 Final Written Decision original - Final Written Decision original (P.T.A.B. Nov. 9, 2022)
|
|
Cite Document
11 Final Written Decision original: Final Written Decision original
Document
IPR2022-00258, No. 11 Final Written Decision original - Final Written Decision original (P.T.A.B. Nov. 9, 2022)
|
|
Cite Document
No. 28
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 28 (N.D.W.Va. Dec. 8, 2023)
|
|
Cite Document
No. 517
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 517 (N.D.W.Va. Jun. 2, 2023)
|
|
Cite Document
No. 486
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 486 (N.D.W.Va. May. 23, 2023)
|
|
Cite Document
No. 41
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 41 (N.D.W.Va. Aug. 23, 2022)
|
|
Cite Document
No. 433
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 433 (N.D.W.Va. Apr. 27, 2023)
|
|
Cite Document
No. 9-1
Document
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd., 1:23-cv-00106, No. 9-1 (N.D.W.Va. Dec. 28, 2023)
|
|
Cite Document
94 Final Written Decision original: Final Written Decision original
Document
IPR2021-00881, No. 94 Final Written Decision original - Final Written Decision original (P.T.A.B. Nov. 9, 2022)
|
|
Cite Document
No. 420
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 420 (N.D.W.Va. Apr. 12, 2023)
|
|
Cite Document
